No continuing education / Category A credit assigned to this presentation.
Presenter: AJB McEwan, MB, FRCPC, FSNMMI
Learning Objectives:
The combination of PET and MRI technologies offers an exciting new future for the imaging sciences. Increasingly imaging is being used not only as a diagnostic tool to identify presence or absence disease, but also as a biomarker to stratify patients for the best therapy, to characterize and measure cancer biology in vivo, and to monitor response to therapy. The ability to integrate the qualitative and functional data on both radiotracer and MRI technologies in the same image will become an increasingly important contributor to the future of precision medicine. The recent installation of a PET/MRI scanner at the Cross Cancer Institute marks an important evolutionary step in the growth of radiopharmaceutical sciences, and will lead to further improvements in access for Canadians to innovative medical technologies, and will likely lead to significant improvements in patient outcomes.
At the end of the lecture participants will:
1. Understand the role of the image as a biomarker
2. Understand the role of functional imaging in disease management
3. Learn the potential role of integrated MRI and PET images in contributing to improved patient outcomes
4. Develop insights into the likely contributions of this technology to the management of patients with cancer and neurological diseases